Tobradex and Eye inflammation - a phase IV clinical study of FDA data

Summary:

Eye inflammation is reported as a side effect among people who take Tobradex (dexamethasone; tobramycin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Tobrex, and have Eye oedema.

The phase IV clinical study analyzes which people have Eye inflammation when taking Tobradex. It is created by eHealthMe based on reports of 3,114 people who have side effects when taking Tobradex from the FDA, and is updated regularly.

What is Tobradex?

Tobradex has active ingredients of dexamethasone; tobramycin. It is often used in eye infection. eHealthMe is studying from 3,154 Tobradex users. Check the latest studies of Tobradex.

What is Eye inflammation?

Eye inflammation is found to be associated with 564 drugs and 582 conditions by eHealthMe. Check the latest studies of Eye inflammation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

3,114 people reported to have side effects when taking Tobradex.
Among them, 53 people (1.7%) have Eye inflammation.

Could Tobradex cause Eye inflammation?

Among these 53 people:

How long have people been on Tobradex when they have Eye inflammation? *

  • < 1 month: 62.5 %
  • 1 - 6 months: 37.5 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Eye inflammation when taking Tobradex? *

  • female: 72.34 %
  • male: 27.66 %

What is the age of people who have Eye inflammation when taking Tobradex? *

  • 0-1: 0.0 %
  • 2-9: 2.78 %
  • 10-19: 0.0 %
  • 20-29: 2.78 %
  • 30-39: 5.56 %
  • 40-49: 11.11 %
  • 50-59: 8.33 %
  • 60+: 69.44 %

What are other drugs people take besides Tobradex? *

  1. Tobrex: 11 people, 20.75%
  2. Balanced Salt Solution: 9 people, 16.98%
  3. Xylocaine: 9 people, 16.98%
  4. Tropicamide: 7 people, 13.21%
  5. Restasis: 6 people, 11.32%
  6. Indomethacin: 6 people, 11.32%
  7. Dupixent: 6 people, 11.32%
  8. Vitamin B12: 6 people, 11.32%
  9. Myfortic: 5 people, 9.43%
  10. Cellcept: 5 people, 9.43%

What are other side effects people have besides Eye inflammation? *

  1. Eye Pain: 25 people, 47.17%
  2. Visual Acuity Reduced (reduced clearness of vision): 15 people, 28.30%
  3. Eye Irritation: 14 people, 26.42%
  4. Foreign Body Sensation In Eyes (feeling of something in eye): 13 people, 24.53%
  5. Photophobia (extreme sensitivity to light): 12 people, 22.64%
  6. Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 11 people, 20.75%
  7. Sinusitis (inflammation of sinus): 11 people, 20.75%
  8. Eye Oedema (swelling or thickening of the macula, the area of the retina responsible for central vision): 11 people, 20.75%
  9. Ocular Hypertension (intraocular pressure higher than normal): 11 people, 20.75%
  10. Stress And Anxiety: 9 people, 16.98%

What are the existing conditions these people have? *

  1. Eye Oedema (swelling or thickening of the macula, the area of the retina responsible for central vision): 11 people, 20.75%
  2. Eye Pain: 10 people, 18.87%
  3. Ocular Hypertension (intraocular pressure higher than normal): 9 people, 16.98%
  4. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 11.32%
  5. Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 6 people, 11.32%
  6. Pemphigoid (tense blisters on the skin): 4 people, 7.55%
  7. Hypoaesthesia Eye (reduced sense of touch or sensation on eyes): 2 people, 3.77%
  8. Dry Eyes (lack of adequate tears): 2 people, 3.77%
  9. Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 2 people, 3.77%
  10. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 1.89%

* Approximation only. Some reports may have incomplete information.

Do you take Tobradex and have Eye inflammation?

- Check whether Eye inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tobradex:

Eye inflammation treatments and more:

How severe was Eye inflammation and when was it recovered:

Expand to all the drugs that have ingredients of dexamethasone; tobramycin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tobradex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye inflammation:

Browse all the conditions that are associated with Eye inflammation:


How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone; tobramycin (the active ingredients of Tobradex) and Tobradex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: